zoloft- sertraline hydrochloride tablet, film coated zoloft- sertraline hydrochloride solution, concentrate
roerig - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - zoloft is indicated for the treatment of the following [see clinical studies (14)] : zoloft is contraindicated in patients: in addition to the contraindications for all zoloft formulations listed above, zoloft oral solution is contraindicated in patients: overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in comparator populations. some studies have reported increases for specific major birth defects; however, these study results are inconclusive [see data] . there are clinical considerations regarding neonates exposed to ssris and snris, including zoloft, during the third trimester of pregnancy [see clinical considerations] . although no teratogenicity was observed in animal reproduction studies, delayed fetal ossification was observed when sertraline was administered during the period of organogenesis at doses less than the maximum recommende
zoloft- sertraline hydrochloride tablet, film coated
pd-rx pharmaceuticals, inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - zoloft is indicated for the treatment of the following [see clinical studies (14)] : - major depressive disorder (mdd) - obsessive-compulsive disorder (ocd) - panic disorder (pd) - posttraumatic stress disorder (ptsd) - social anxiety disorder (sad) - premenstrual dysphoric disorder (pmdd) zoloft is contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . - taking pimozide [see drug interactions (7.1)] . - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. in addition to the contraindications for all zoloft formulations listed above, zoloft ora
zoloft- sertraline hydrochloride tablet, film coated
remedyrepack inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - zoloft is indicated for the treatment of the following [see clinical studies (14)] : - major depressive disorder (mdd) - obsessive-compulsive disorder (ocd) - panic disorder (pd) - posttraumatic stress disorder (ptsd) - social anxiety disorder (sad) - premenstrual dysphoric disorder (pmdd) zoloft is contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . - taking pimozide [see drug interactions (7.1)] . - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. in addition to the contraindications for all zoloft formulations listed above, zoloft ora
metronidazole 500mg tablets
accord-uk ltd - metronidazole - oral tablet - 500mg
pylera 140/125/12 milligram capsule
allergan pharmaceuticals international limited - bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride - capsule - 140/125/12 milligram - combinations for eradication of helicobacter pylori
norvir ritonavir 600mg/7.5ml oral liquid bottle
abbvie pty ltd - ritonavir -
hypnodorm
teva pharmaceutical industries ltd, israel - flunitrazepam - tablets - flunitrazepam 2 mg - flunitrazepam - flunitrazepam - insomnia of various etiology.
vandazole- metronidazole gel
upsher-smith laboratories, llc - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - vandazole® is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis) in post-menarchal females. the use of vandazole is contraindicated in patients with a history of hypersensitivity to metronidazole, other nitroimidazole derivatives, or parabens. reported reactions include urticaria; erythematous rash; stevens-johnson syndrome, toxic epidermal necrolysis, flushing; nasal congestion; dryness of the mouth, vagina, or vulva; fever; pruritus; fleeting joint pains [see adverse reactions (6.2)] . use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. do not administer vandazole to patients who have taken disulfiram within the last two weeks [see adverse reactions (6.2)] . use of oral metronidazole is associated with a disulfiram-like reaction to alcohol, including abdominal cramps, nausea, vomiting, he
vandazole- metronidazole gel
rpk pharmaceuticals, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - vandazole® is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis) in post-menarchal females. the use of vandazole is contraindicated in patients with a history of hypersensitivity to metronidazole, other nitroimidazole derivatives, or parabens. reported reactions include urticaria; erythematous rash; stevens-johnson syndrome, toxic epidermal necrolysis, flushing; nasal congestion; dryness of the mouth, vagina, or vulva; fever; pruritus; fleeting joint pains [see adverse reactions (6.2)] . use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. do not administer vandazole to patients who have taken disulfiram within the last two weeks [see adverse reactions (6.2)] . use of oral metronidazole is associated with a disulfiram-like reaction to alcohol, including abdominal cramps, nausea, vomiting, he
vandazole- metronidazole gel
remedyrepack inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - vandazole is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis) in non-pregnant women. the use of vandazole is contraindicated in patients with a history of hypersensitivity to metronidazole, other nitroimidazole derivatives, or parabens. reported reactions include urticaria; erythematous rash; stevens-johnson syndrome, toxic epidermal necrolysis, flushing; nasal congestion; dryness of the mouth, vagina, or vulva; fever; pruritus; fleeting joint pains [ see adverse reactions ( 6.2) ]. use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. do not administer vandazole to patients who have taken disulfiram within the last two weeks [ see adverse reactions ( 6.2) ]. use